(Q63336422)

English

Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia

clinical trial

Statements

A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of SER120 Nasal Spray Formulations in Patients With Nocturia (English)
0 references
May 2011
0 references
October 2012
0 references
816
0 references
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit